Financial results - ERITROFARM S.R.L.

Financial Summary - Eritrofarm S.r.l.
Unique identification code: 8684656
Registration number: J35/891/1995
Nace: 4773
Sales - Ron
215.588
Net Profit - Ron
24.012
Employees
2
Open Account
Company Eritrofarm S.r.l. with Fiscal Code 8684656 recorded a turnover of 2024 of 215.588, with a net profit of 24.012 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Eritrofarm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 127.943 118.037 122.496 134.224 138.747 157.456 159.541 179.313 196.055 215.588
Total Income - EUR 133.812 121.019 124.064 135.741 140.807 160.136 160.764 184.076 203.869 221.834
Total Expenses - EUR 130.998 120.486 118.340 127.519 135.983 141.639 144.599 161.948 177.998 192.365
Gross Profit/Loss - EUR 2.814 534 5.724 8.222 4.824 18.498 16.165 22.128 25.871 29.469
Net Profit/Loss - EUR 2.364 448 4.454 6.865 3.417 16.938 14.590 20.324 23.880 24.012
Employees 2 2 2 2 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 10.6%, from 196.055 euro in the year 2023, to 215.588 euro in 2024. The Net Profit increased by 266 euro, from 23.880 euro in 2023, to 24.012 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Eritrofarm S.r.l.

Rating financiar

Financial Rating -
ERITROFARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Eritrofarm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Eritrofarm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Eritrofarm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Eritrofarm S.r.l. - CUI 8684656

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 15.619 15.460 15.198 14.919 10.034 9.844 9.626 9.655 9.626 9.572
Current Assets 55.546 44.200 46.613 54.910 54.686 61.758 65.358 61.590 77.763 86.803
Inventories 30.223 28.937 25.767 29.609 29.590 32.135 29.094 30.173 34.516 37.701
Receivables 10.501 4.862 13.464 17.718 14.896 21.347 20.708 20.908 21.390 18.562
Cash 14.822 10.401 7.383 7.582 10.199 8.276 15.557 10.509 21.857 30.539
Shareholders Funds 12.703 13.022 17.256 23.804 13.102 29.791 23.880 29.644 33.171 33.251
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 58.462 46.638 44.556 46.025 51.618 41.811 51.103 41.602 54.219 63.124
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 86.803 euro in 2024 which includes Inventories of 37.701 euro, Receivables of 18.562 euro and cash availability of 30.539 euro.
The company's Equity was valued at 33.251 euro, while total Liabilities amounted to 63.124 euro. Equity increased by 266 euro, from 33.171 euro in 2023, to 33.251 in 2024.

Risk Reports Prices

Reviews - Eritrofarm S.r.l.

Comments - Eritrofarm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.